0000905148-24-000307.txt : 20240125 0000905148-24-000307.hdr.sgml : 20240125 20240125211711 ACCESSION NUMBER: 0000905148-24-000307 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240123 FILED AS OF DATE: 20240125 DATE AS OF CHANGE: 20240125 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Santos David A CENTRAL INDEX KEY: 0001820066 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-29889 FILM NUMBER: 24563916 MAIL ADDRESS: STREET 1: RIGEL PHARMACEUTICALS, INC. STREET 2: 1180 VETERANS BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RIGEL PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001034842 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 943248524 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 611 GATEWAY BOULEVARD, SUITE 900 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-624-1100 MAIL ADDRESS: STREET 1: 611 GATEWAY BOULEVARD, SUITE 900 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 form4.xml X0508 4 2024-01-23 0001034842 RIGEL PHARMACEUTICALS INC RIGL 0001820066 Santos David A RIGEL PHARMACEUTICALS, INC. 611 GATEWAY BLVD, SUITE 900 SOUTH SAN FRANCISCO CA 94080 true EVP, Chief Commercial Officer false Common Stock 2024-01-23 4 A 0 209000 0 A 363612 D Employee Stock Option (Right to Buy) 1.27 2024-01-23 4 A 0 157000 0 A 2034-01-23 Common Stock 157000 157000 D The shares of common stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall vest annually over three (3) years from February 1, 2024, with the first annual vest occurring on February 1, 2025. Includes 10,000 shares acquired under the Issuer's stock purchase plan. The shares of common stock subject to the option vest monthly over three (3) years from the vesting commencement date of January 23, 2024, subject to the Reporting Person's continuous service to the issuer through each such period. /s/ Raymond Furey (Attorney-in-Fact) 2024-01-25